Kd. Lillemoe et al., CHEMICAL SPLANCHNICECTOMY IN PATIENTS WITH UNRESECTABLE PANCREATIC-CANCER - A PROSPECTIVE RANDOMIZED TRIAL, Annals of surgery, 217(5), 1993, pp. 447-457
Objective A prospective, randomized, double-blind study was completed
comparing intraoperative chemical splanchnicectomy with 50% alcohol ve
rsus a placebo injection of saline in patients with histologically pro
ven unresectable pancreatic cancer. Methods Standardized assessment of
pain, mood, and disability due to pain was completed, preoperatively
and at 2-month intervals until death. Chemical splanchnicectomy with a
lcohol was performed in 65 patients, whereas 72 patients received the
placebo. The two groups were similar with respect to age, sex, locatio
n, and stage of tumor, operation performed, the use of postoperative c
hemo- and radiation therapy, and initial assessment scores for pain, m
ood, and disability. Results No differences in hospital mortality or c
omplications, return to oral intake, or length of hospital stay were o
bserved. Mean pain scores were significantly lower in the alcohol grou
p at 2-, 4-, and 6-month follow-up and at the final assessment (p<0.05
). To further determine the effect of chemical splanchnicectomy, patie
nts were stratified into those with and without preoperative pain. In
patients without preoperative pain, alcohol significantly reduced pain
scores and delayed or prevented the subsequent onset of pain (p<0.05)
. In patients with significant preoperative pain, alcohol significantl
y reduced existing pain (p<0.05). Furthermore, patients with preexisti
ng pain who received alcohol showed a significant improvement in survi
val when compared with controls (p<0.0001). Conclusion The results sug
gest that intraoperative chemical splanchnicectomy with alcohol signif
icantly reduces or prevents pain in patients with unresectable pancrea
tic cancer.